Temporal activity of plasminogen activators and matrix metalloproteinases during cutaneous wound repair

被引:50
|
作者
Arumugam, S
Jang, YC
Chen-Jensen, C
Gibran, NS
Isik, FF
机构
[1] Vet Adm Puget Sound Hlth Care Syst, Dept Surg, Seattle, WA 98108 USA
[2] Univ Washington, Harborview Med Ctr, Dept Surg, Seattle, WA 98104 USA
[3] Univ Illinois, Coll Med, Chicago, IL USA
关键词
D O I
10.1067/msy.1999.98254
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. Response to tissue injury begins with the deposition of a fibrin-rich clot or the provisional matrix. The provisional matrix consists of plasma-borne matrix molecules that serve as scaffolding for the ensuing migration of cells. During wound repair multiple cell types must migrate through the clot-matrix scaffolding: The migration of these cells through the matrix is dependent on the activity of the fibrinolytic and proteolytic systems, which include the plasminogen activator (PA) system and matrix metalloproteinases (MMP). The aim of this study was to better understand the temporal activity of these enzymes during normal wound repair. Methods. We used the murine excisional wound model and extracted proteins under nonreducing conditions, With use Of gelatin and casein zymography, we determined the activity of the MMPs during the course of wound repair In addition, we quantified the activity of MMP-2 and MMP-9 by a standardized assay. Plasminogen zymograms were used to detect urokinase PA and tissue PA activity. Western blots were used to detect the natural inhibitor of PAs, plasminogen activator inhibitor type 1. Results. Our results demonstrate the temporal activity of MMP-2, MMP-3, MMP-7, and MMP-9 during the course of normal dermal repair. The activity of urokinase PA and tissue PA were also determined; it preceded the activity of the MMPs. Conclusions. We demonstrate the temporal activity of the 2 protease families, MMPs and PAs, in the normal process of cutaneous wound healing.
引用
收藏
页码:587 / 593
页数:7
相关论文
共 50 条
  • [31] Matrix remodeling by MMPs during wound repair
    Rohani, Maryam G.
    Parks, William C.
    [J]. MATRIX BIOLOGY, 2015, 44-46 : 113 - 121
  • [32] Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure
    Heymans, S
    Luttun, A
    Nuyens, D
    Theilmeier, G
    Creemers, E
    Moons, L
    Dyspersin, GD
    Cleutjens, JPM
    Shipley, M
    Angellilo, A
    Levi, M
    Nübe, O
    Baker, A
    Keshet, E
    Lupu, F
    Herbert, JM
    Smits, JFM
    Shapiro, SD
    Baes, M
    Borgers, M
    Collen, D
    Daemen, MJAP
    Carmeliet, P
    [J]. NATURE MEDICINE, 1999, 5 (10) : 1135 - 1142
  • [33] Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure
    S. Heymans
    A. Luttun
    D. Nuyens
    G. Theilmeier
    E. Creemers
    L. Moons
    G.D. Dyspersin
    J.P.M. Cleutjens
    M. Shipley
    A. Angellilo
    M. Levi
    O. Nüβe
    A. Baker
    E. Keshet
    F. Lupu
    J-M Herbert
    J.F.M. Smits
    S.D. Shapiro
    M. Baes
    M. Borgers
    D. Collen
    M. J.A.P. Daemen
    P. Carmeliet
    [J]. Nature Medicine, 1999, 5 : 1135 - 1142
  • [34] Matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) during rat tracheal wound healing
    Horiba, K
    Fukuda, Y
    StetlerStevenson, WG
    Liotta, LA
    Ferrans, VJ
    [J]. LABORATORY INVESTIGATION, 1996, 74 (01) : 917 - 917
  • [35] INCREASED ACTIVITY OF PLASMINOGEN ACTIVATORS DURING INVOLUTION OF THE RAT VENTRAL PROSTATE
    RENNIE, PS
    BOUFFARD, R
    BRUCHOVSKY, N
    CHENG, H
    [J]. BIOCHEMICAL JOURNAL, 1984, 221 (01) : 171 - 178
  • [36] Matrix metalloproteinase activity is enhanced during corneal wound repair in high glucose condition
    Takahashi, H
    Akiba, K
    Noguchi, T
    Ohmura, T
    Takahashi, R
    Ezure, Y
    Ohara, K
    Zieske, JD
    [J]. CURRENT EYE RESEARCH, 2000, 21 (02) : 608 - 615
  • [37] The effect of IL-1α on the expression of matrix metalloproteinases, plasminogen activators, and their inhibitors in osteoblastic ROS 17/2.8 cells
    Fujisaki, K
    Tanabe, N
    Suzuki, N
    Mitsui, N
    Oka, H
    Ito, K
    Maeno, M
    [J]. LIFE SCIENCES, 2006, 78 (17) : 1975 - 1982
  • [38] Blood-brain barrier breakdown after ischaemic stroke: the role of oxidative stress, plasminogen activators and matrix metalloproteinases
    Vashisht, K.
    Srivastava, K.
    Bayraktutan, U.
    [J]. INTERNATIONAL JOURNAL OF STROKE, 2012, 7 : 59 - 59
  • [39] Determination of metalloproteinases, plasminogen-activators and their inhibitors in the synovial fluids of patients with rheumatoid arthritis during chemical synoviorthesis
    Blaser, J
    Triebel, S
    Maasjosthusmann, U
    Romisch, J
    KrahlMateblowski, U
    Freudenberg, W
    Fricke, R
    Tschesche, H
    [J]. CLINICA CHIMICA ACTA, 1996, 244 (01) : 17 - 33
  • [40] Expression of matrix metalloproteinases and their inhibitors during hepatic tissue repair in the rat
    Knittel, T
    Mehde, M
    Grundmann, A
    Saile, B
    Scharf, JG
    Ramadori, G
    [J]. HISTOCHEMISTRY AND CELL BIOLOGY, 2000, 113 (06) : 443 - 453